Juanita Lishman
Overview
Explore the profile of Juanita Lishman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lishman J, Frigati L, Rabie H
Curr Opin HIV AIDS
. 2024 Aug;
19(6):330-337.
PMID: 39145760
Purpose Of Review: HIV-associated tuberculosis (TB) remains a major driver of morbidity and mortality in children and adolescents younger than 15 years (CLWH). The purpose of this review is to...
2.
Lishman J, Abraham D, Fourie B, Yunis N, Redfern A, van der Zalm M, et al.
Arch Dis Child
. 2023 May;
108(10):792-798.
PMID: 37236771
Background: Despite the life-threatening presentation of multisystem inflammatory syndrome in children (MIS-C), the overall prognosis is favourable in centres with access to appropriate supportive care. In this study, we investigate...
3.
Redfern A, van der Zalm M, Lishman J, Goussard P, Smit L, Dagan R, et al.
Pediatr Infect Dis J
. 2023 May;
42(8):672-678.
PMID: 37171967
Background: Data from low- and middle-income countries (LMICs) show higher morbidity and mortality in children with acute respiratory illness (ARI) from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). However, whether SARS-CoV-2...
4.
Finlayson H, Lishman J, Palmer M
Curr Opin Pediatr
. 2023 Feb;
35(2):166-175.
PMID: 36749063
Purpose Of Review: The current review identifies recent advances in the prevention, diagnosis, and treatment of childhood tuberculosis (TB) with a focus on the WHO's updated TB management guidelines released...
5.
Abraham D, Butters C, Yunis N, Lishman J, Scott C, van der Zalm M, et al.
Pediatr Infect Dis J
. 2022 Sep;
41(12):e510-e512.
PMID: 36102719
The effects of SARS-CoV-2 variants on disease phenotype and severity of multisystem inflammatory syndrome in children (MIS-C) are unknown. We compared the clinical phenotype of MIS-C in 129 South African...
6.
Smit L, Redfern A, Murray S, Lishman J, van der Zalm M, van Zyl G, et al.
Afr J Emerg Med
. 2022 May;
12(3):177-182.
PMID: 35496826
Background: Identification of SARS-CoV-2 infected individuals is imperative to prevent hospital transmission, but symptom-based screening may fail to identify asymptomatic/mildly symptomatic infectious children and their caregivers. Methods: A COVID-19 period...
7.
Rabie H, Lishman J, Frigati L
Lancet HIV
. 2022 Apr;
9(5):e301-e302.
PMID: 35489373
No abstract available.
8.
Essajee F, Lishman J, Solomons R, Abraham D, Goussard P, van Toorn R
BMJ Case Rep
. 2021 Aug;
14(8).
PMID: 34380685
We report on a unique case of a 7-year-old girl with new onset ocular myasthenia gravis shortly after recovery from multisystem inflammatory syndrome in children (MIS-C) temporally associated with SARS-CoV-2...
9.
Lishman J, Smit L, Redfern A
Afr J Emerg Med
. 2021 Mar;
11(1):158-164.
PMID: 33680738
Background: Young infants with a possible serious bacterial infection (SBI) are a very common presentation to emergency centres (ECs). It is often difficult to distinguish clinically between self-limiting viral infections...
10.
van der Zalm M, Lishman J, Verhagen L, Redfern A, Smit L, Barday M, et al.
Clin Infect Dis
. 2020 Nov;
72(12):e938-e944.
PMID: 33170927
Background: Children seem relatively protected from serious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease, but little is known about children living in settings with high tuberculosis and human immunodeficiency...